CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS: CNBX · Delayed Price · USD
0.0120
0.00 (0.00%)
Apr 22, 2024, 10:57 AM EDT - Market open
CNBX Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
| Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 0 | 0 | 4 | 24 | 26 | 34 | 110 | 113 | 5 | 18 | 50 | Upgrade
|
| Market Cap Growth | - | -96.41% | -82.35% | -8.37% | -25.37% | -68.56% | -2.70% | 2088.58% | -71.62% | -63.83% | 49018.79% | Upgrade
|
| Enterprise Value | 2 | 1 | 6 | 23 | 25 | 34 | 108 | 109 | 5 | 18 | 50 | Upgrade
|
| PE Ratio | -0.29 | -0.04 | -1.10 | -9.46 | -8.26 | 30.40 | -29.00 | -58.22 | -16.75 | -33.48 | -185.60 | Upgrade
|
| PS Ratio | 0.69 | 0.36 | 138.76 | - | 3590.80 | 3498.65 | 11409.15 | 19807.07 | 45.73 | - | - | Upgrade
|
| PB Ratio | -0.16 | -0.07 | -2.55 | 13.04 | 14.56 | 2.34 | 41.41 | 38.31 | -11.00 | -58.54 | 11.26 | Upgrade
|
| P/FCF Ratio | -1.90 | -1.33 | -2.47 | -9.44 | -9.02 | -10.40 | -37.55 | -113.80 | -42.83 | -99.54 | -220.79 | Upgrade
|
| P/OCF Ratio | -1.91 | -1.33 | -2.48 | -9.45 | -9.26 | -11.13 | -55.47 | -130.37 | -42.83 | -101.23 | -256.44 | Upgrade
|
| EV/Sales Ratio | 3.01 | 3.32 | 193.54 | - | 3482.15 | 3471.63 | 11264.00 | 19214.59 | 45.56 | - | - | Upgrade
|
| EV/EBITDA Ratio | -0.54 | -1.65 | -1.67 | -7.32 | -3.44 | -11.04 | -28.82 | -59.14 | -18.36 | -33.82 | -232.54 | Upgrade
|
| EV/EBIT Ratio | -0.51 | -1.38 | -1.58 | -6.84 | -3.34 | -10.41 | -28.16 | -58.91 | -18.26 | -33.74 | -232.45 | Upgrade
|
| EV/FCF Ratio | -8.32 | -12.11 | -3.45 | -9.24 | -8.74 | -10.32 | -37.07 | -110.39 | -42.67 | -99.41 | -220.36 | Upgrade
|
| Debt / Equity Ratio | -0.55 | -0.67 | -1.08 | 0.48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Debt / EBITDA Ratio | -0.43 | -1.63 | -0.51 | -0.28 | - | - | - | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | -6.61 | -11.94 | -1.05 | -0.35 | - | - | - | - | - | - | - | Upgrade
|
| Quick Ratio | 0.06 | 0.09 | 0.08 | 1.25 | 2.04 | 8.67 | 3.01 | 5.03 | 0.04 | 0.07 | 1.33 | Upgrade
|
| Current Ratio | 0.06 | 0.09 | 0.08 | 1.25 | 2.04 | 9.81 | 3.01 | 5.03 | 0.04 | 0.08 | 1.52 | Upgrade
|
| Asset Turnover | 1.15 | 0.82 | 0.04 | 0 | 0.00 | 0.00 | 0.00 | 0.00 | 4.74 | 0 | 0 | Upgrade
|
| Interest Coverage | 0 | -793.34 | -2320.48 | -1087.49 | -374.21 | -180.05 | -4470.34 | -423.94 | -10.33 | -178.30 | -222.59 | Upgrade
|
| Return on Equity (ROE) | 53.03% | 183.92% | 230.90% | -137.88% | -176.40% | 7.68% | -142.76% | -65.81% | 65.71% | 174.85% | -6.07% | Upgrade
|
| Return on Assets (ROA) | -762.96% | -743.48% | -464.64% | -80.87% | -140.25% | 7.46% | -118.58% | -53.16% | -1295.25% | -1886.10% | -5.97% | Upgrade
|
| Return on Capital (ROIC) | 66.88% | 138.25% | -2337.17% | -97.10% | -172.48% | -21.66% | -143.97% | -63.09% | 60.04% | 174.25% | -4.86% | Upgrade
|
| Earnings Yield | -334.98% | -2487.81% | -90.67% | -10.57% | -12.11% | 3.29% | -3.45% | -1.72% | -5.97% | -2.99% | -0.54% | Upgrade
|
| FCF Yield | -52.37% | -75.45% | -40.43% | -10.59% | -11.09% | -9.61% | -2.66% | -0.88% | -2.33% | -1.00% | -0.45% | Upgrade
|
| Buyback Yield / Dilution | -1478.62% | -621.77% | -5.92% | -2.95% | -1.59% | -10.03% | -9.06% | -6.90% | -2.53% | -0.46% | -7269.29% | Upgrade
|
| Total Shareholder Return | -1478.62% | -621.77% | -5.92% | -2.95% | -1.59% | -10.03% | -9.06% | -6.90% | -2.53% | -0.46% | -7269.29% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.